BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 3738363)

  • 1. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H; Niculescu F; Cristea A; Vlaicu R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986; 31(1):35-40. PubMed ID: 3738363
    [No Abstract]   [Full Text] [Related]  

  • 2. The C5b-9 complex: subunit composition of the classical and alternative pathway-generated complex.
    Podack ER; Kolb WP; Muller-Eberhard HJ
    J Immunol; 1976 May; 116(5):1431-4. PubMed ID: 1270802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C6, C7, C8 and C9].
    Hatanaka M; Kitano E
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():90-3. PubMed ID: 20942009
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic tests: C6, C7, C8 and C9].
    Hatanaka M; Shimizu A
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():92-4. PubMed ID: 16111197
    [No Abstract]   [Full Text] [Related]  

  • 5. [C6, C7, C8 and C9].
    Hatanaka M; Shimizu A
    Nihon Rinsho; 1999 Nov; 57 Suppl():71-4. PubMed ID: 10635778
    [No Abstract]   [Full Text] [Related]  

  • 6. Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.
    Biesecker G; Lavin L; Ziskind M; Koffler D
    N Engl J Med; 1982 Feb; 306(5):264-70. PubMed ID: 7054697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypochlorite-induced alterations to canine serum complement.
    Boyer JT; Wyde P; Bier M
    Clin Exp Immunol; 1975 Aug; 21(2):345-50. PubMed ID: 1102168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL; Kolb WP; Sodetz JM
    J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C5b-6 complex: reaction with C7, C8, C9.
    Podack ER; Biesecker G; Kolb WP; Müller-Eberhard HJ
    J Immunol; 1978 Aug; 121(2):484-90. PubMed ID: 681745
    [No Abstract]   [Full Text] [Related]  

  • 11. Reaction of partial identity between the C56-9 complex derived from target membranes and from inulin-activated serum.
    Bhakdi S; Bhakdi-Lehnen B; Ey P; Bjerrum OJ
    Monogr Allergy; 1977; 12():56-61. PubMed ID: 411027
    [No Abstract]   [Full Text] [Related]  

  • 12. Testing of hemolytic complement components in domestic animals.
    Barta O; Hubbert NL
    Am J Vet Res; 1978 Aug; 39(8):1303-8. PubMed ID: 697137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size of the transmembrane channels produced by complement proteins C5b-8.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1982 Sep; 129(3):1143-6. PubMed ID: 6286757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of soluble terminal complement complex assembled in C8beta-deficient plasma and serum.
    Høgåsen K; Mollnes TE; Nürnberger W; Pausa M; Fukumori Y; Tedesco F
    Scand J Immunol; 1998 Sep; 48(3):261-8. PubMed ID: 9743210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-fixing adrenal autoantibodies as a marker for predicting onset of idiopathic Addison's disease.
    Betterle C; Zanette F; Zanchetta R; Pedini B; Trevisan A; Mantero F; Rigon F
    Lancet; 1983 Jun; 1(8336):1238-41. PubMed ID: 6134038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimeric C9 within C5b-9 is required for inner membrane damage to Escherichia coli J5 during complement killing.
    Bloch EF; Schmetz MA; Foulds J; Hammer CH; Frank MM; Joiner KA
    J Immunol; 1987 Feb; 138(3):842-8. PubMed ID: 3100618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic action and other metabolic consequences of terminal complement proteins.
    Shin ML; Carney DF
    Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement-mediated serum cytotoxicity for Leishmania major amastigotes: killing by serum deficient in early components of the membrane attack complex.
    Hoover DL; Berger M; Hammer CH; Meltzer MS
    J Immunol; 1985 Jul; 135(1):570-4. PubMed ID: 3998474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.